1 completed, 1 not yet recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Fragile X Syndrome (FXS): new trials by email Literature Review of Fragile X Syndrome (FXS) trials Research Report on Fragile X Syndrome (FXS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Effects and Safety of Codabakalner for the Treatment of FXS in Male Participants and Adult Participants With ADS Codabakalner, Placebo - Fragile X Syndrome (FXS), Autism Spectrum Disorder (ASD) | Phase 2 / Phase 3 | Not yet recruiting | Spinogenix | 120 | 2026-12-01 | 2026-10-09 |
| Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome ZYN002, Placebo - Fragile X Syndrome, Fragile X Syndrome (FXS) | Phase 3 | Completed | Harmony Biosciences Management, Inc. | 257 | 2021-09-13 | 2026-09-01 |
Fragile X Syndrome (2) · Autism Spectrum Disorder (1) · Autistic Disorder (1)
Chromosome Disorders (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Genetic Diseases, X-Linked (2) · Heredodegenerative Disorders, Nervous System (2) · Intellectual Disability (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Sex Chromosome Disorders (2) · X-Linked Intellectual Disability (2) · Child Development Disorders, Pervasive (1) · Mental Disorders (1) · Neurodevelopmental Disorders (1)
Harmony Biosciences Management, Inc. (1) · Spinogenix (1)
Australia (1) · Ireland (1) · New Zealand (1) · United Kingdom (1) · United States (1)